Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9718848 Compounds

Patent 9718848 was granted and assigned to GlaxoSmithKline on August, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

GlaxoSmithKline

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

97188480

Patent Inventor Names

Kevin J. Duffy0

Jerry Adams0

Yiqian Lian0

Date of Patent

August 1, 2017

Patent Application Number

153689210

Date Filed

December 5, 2016

Patent Citations Received

‌

US Patent 11673891 Imidazopyrimidine compounds and uses thereof

‌

US Patent 11773132 Cyclic di-nucleotides as stimulator of interferon genes modulators

‌

US Patent 11666594 Antibody-drug conjugates comprising a cyclic dinucleotide

‌

US Patent 11691990 Salts of compounds and crystals thereof

Patent Primary Examiner

‌

Traviss C Mcintosh, III

Patent abstract

A compound of Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9718848 Compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API